L-DOPA modifies the antidepressant-like effects of reboxetine and fluoxetine in rats.
about
Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson's disease.Impairment of Serotonergic Transmission by the Antiparkinsonian Drug L-DOPA: Mechanisms and Clinical ImplicationsThe acute and long-term L-DOPA effects are independent from changes in the activity of dorsal raphe serotonergic neurons in 6-OHDA lesioned rats.
P2860
L-DOPA modifies the antidepressant-like effects of reboxetine and fluoxetine in rats.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
L-DOPA modifies the antidepressant-like effects of reboxetine and fluoxetine in rats.
@en
L-DOPA modifies the antidepressant-like effects of reboxetine and fluoxetine in rats.
@nl
type
label
L-DOPA modifies the antidepressant-like effects of reboxetine and fluoxetine in rats.
@en
L-DOPA modifies the antidepressant-like effects of reboxetine and fluoxetine in rats.
@nl
prefLabel
L-DOPA modifies the antidepressant-like effects of reboxetine and fluoxetine in rats.
@en
L-DOPA modifies the antidepressant-like effects of reboxetine and fluoxetine in rats.
@nl
P50
P1433
P1476
L-DOPA modifies the antidepressant-like effects of reboxetine and fluoxetine in rats.
@en
P2093
P304
P356
10.1016/J.NEUROPHARM.2012.11.016
P577
2012-12-02T00:00:00Z